AAAAAA

   
Results: 1-10 |
Results: 10
THE ANTICOAGULATORY EX-VIVO ACTIVITY OF THE BIS-ALDONIC ACID-AMIDES APROSULATE AND LW-10187
Authors: BREITER N RAAKE W ASAI F SUGIDACHI A
Citation: N. Breiter et al., THE ANTICOAGULATORY EX-VIVO ACTIVITY OF THE BIS-ALDONIC ACID-AMIDES APROSULATE AND LW-10187, Thrombosis and haemostasis, 73(6), 1995, pp. 1317-1317
EFFECT OF DIFFERENT ANTITHROMBOTIC COMPOUNDS IS AN ARTERIAL AND A VENOUS THROMBOSIS MODEL
Authors: BREITER N RAAKE W KLAUSER R MEINETSBERGER E
Citation: N. Breiter et al., EFFECT OF DIFFERENT ANTITHROMBOTIC COMPOUNDS IS AN ARTERIAL AND A VENOUS THROMBOSIS MODEL, Thrombosis and haemostasis, 73(6), 1995, pp. 1318-1318
DIFFERENTIAL INHIBITION OF CLOT-ASSOCIATED THROMBIN BY VARIOUS ANTICOAGULANTS
Authors: KLAUSER RJ RAAKE W MEINETSBERGER E BREITER N
Citation: Rj. Klauser et al., DIFFERENTIAL INHIBITION OF CLOT-ASSOCIATED THROMBIN BY VARIOUS ANTICOAGULANTS, Thrombosis and haemostasis, 73(6), 1995, pp. 1321-1321
EFFECT OF REPEATED ADMINISTRATION OF A SYNTHETIC HEPARIN ANALOG ON TISSUE FACTOR PATHWAY INHIBITOR (TFPI) RELEASE
Authors: JESKE W KAMMEREIT A KLAUSER R RAAKE W ECKENBERGER P HOPPENSTEADT D FAREED J
Citation: W. Jeske et al., EFFECT OF REPEATED ADMINISTRATION OF A SYNTHETIC HEPARIN ANALOG ON TISSUE FACTOR PATHWAY INHIBITOR (TFPI) RELEASE, The FASEB journal, 8(5), 1994, pp. 10000641-10000641
DERIVATIVES OF BIS-ALDONIC ACID-AMIDES AND THEIR ANTICOAGULANT AND ANTITHROMBOTIC PROPERTIES
Authors: RAAKE W KLAUSER RJ ELLING H ZEILLER P MEINETSBERGER E
Citation: W. Raake et al., DERIVATIVES OF BIS-ALDONIC ACID-AMIDES AND THEIR ANTICOAGULANT AND ANTITHROMBOTIC PROPERTIES, Seminars in thrombosis and hemostasis, 20(2), 1994, pp. 176-181
THE IN-VITRO INFLUENCE OF SULFATED BIS-LACTOBIONIC ACID-AMIDES ON O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE, DNASE-I, NUCLEIC-ACID SYNTHESIS AND CHROMATIN STRUCTURE
Authors: IGNATIUS A MEINETSBERGER E RAAKE W TEMPEL K
Citation: A. Ignatius et al., THE IN-VITRO INFLUENCE OF SULFATED BIS-LACTOBIONIC ACID-AMIDES ON O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE, DNASE-I, NUCLEIC-ACID SYNTHESIS AND CHROMATIN STRUCTURE, Biochemical pharmacology, 47(2), 1994, pp. 203-208
EFFECT OF A NOVEL SULFATED LACTOBIONIC ACID AMIDE DERIVED ANTITHROMBOTIC AGENT (APROSULATE) ON HEMOSTATIC FIBRINOLYTIC PARAMETERS AND TISSUE FACTOR PATHWAY INHIBITOR
Authors: JESKE W RAAKE W KAMMEREIT A KLAUSER R KLEPSCH U FAREED J
Citation: W. Jeske et al., EFFECT OF A NOVEL SULFATED LACTOBIONIC ACID AMIDE DERIVED ANTITHROMBOTIC AGENT (APROSULATE) ON HEMOSTATIC FIBRINOLYTIC PARAMETERS AND TISSUE FACTOR PATHWAY INHIBITOR, Thrombosis and haemostasis, 69(6), 1993, pp. 673-673
RELATIVE NEUTRALIZATION OF THE ANTICOAGULANT ACTIVITY OF A NEWLY DEVELOPED SULFATED LACTOBIONIC ACID-DERIVED ANTITHROMBOTIC AGENT (APROSULATE(R))
Authors: KIJOWSKI R JESKE W IQBAL O HOPPENSTEADT D RAAKE W FAREED J
Citation: R. Kijowski et al., RELATIVE NEUTRALIZATION OF THE ANTICOAGULANT ACTIVITY OF A NEWLY DEVELOPED SULFATED LACTOBIONIC ACID-DERIVED ANTITHROMBOTIC AGENT (APROSULATE(R)), Thrombosis and haemostasis, 69(6), 1993, pp. 1317-1317
ANTITHROMBOTIC ACTIVITIES OF APROSULATE SODIUM (LW-10082) AND ITS NEUTRALIZATION BY PROTAMINE
Authors: RAAKE W KLAUSER RJ MEINETSBERGER E
Citation: W. Raake et al., ANTITHROMBOTIC ACTIVITIES OF APROSULATE SODIUM (LW-10082) AND ITS NEUTRALIZATION BY PROTAMINE, Seminars in thrombosis and hemostasis, 19, 1993, pp. 183-185
EVIDENCE FOR THE ROLE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) RELEASE IN THE MEDIATION OF THE ANTITHROMBOTIC ACTIONS OF LOW-MOLECULAR-WEIGHT HEPARINS (LWMHS) AND A SYNTHETIC SULFATED LACTOBIONIC ACID-DERIVATIVE
Authors: JESKE W KAMMEREIT A KLAUSER R RAAKE W ECKENBERGER P HOPPENSTEADT D FAREED J
Citation: W. Jeske et al., EVIDENCE FOR THE ROLE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) RELEASE IN THE MEDIATION OF THE ANTITHROMBOTIC ACTIONS OF LOW-MOLECULAR-WEIGHT HEPARINS (LWMHS) AND A SYNTHETIC SULFATED LACTOBIONIC ACID-DERIVATIVE, Blood, 82(10), 1993, pp. 10000273-10000273
Risultati: 1-10 |